US$ 28.16
is tirzepatide better for weight loss than semaglutide causes more π Semaglutide vs. Tirzepatide β
Description
21 Based on results of the PIONEER 6 study alone, no conclusion as to whether semaglutide tablets offer any CV benefit can be made
Statistical analysis A sample size of 156 participants (104 randomized to survodutide and 52 to placebo) was calculated to provide 90% overall power to demonstrate superiority of survodutide 6.0 mg over placebo for both co-primary endpoints, each at a two-sided significance level of 0.05, assuming an early treatment discontinuation rate of 15%

Research from the STEP 1 exploratory analysis using DEXA scans revealed that semaglutide-induced weight loss comprises approximately 60 percent fat mass and 40 percent lean mass

By Anthony S

The combination has not been formally tested in any published clinical trial as of May 2026
For others, it can be more severe